Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors

BACKGROUND: Choice of initial antiretroviral therapy regimen may help children with HIV maintain optimal, continuous therapy. We assessed treatment-naïve children for differences in time to treatment disruption across randomly-assigned protease inhibitor versus non-nucleoside reverse transcriptase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Dwight E., Ludema, Christina, Cole, Stephen R., Golin, Carol E., Miller, William C., Warshaw, Meredith G., McKinney, Ross E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682873/
https://www.ncbi.nlm.nih.gov/pubmed/33226999
http://dx.doi.org/10.1371/journal.pone.0242405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682873/
https://www.ncbi.nlm.nih.gov/pubmed/33226999
http://dx.doi.org/10.1371/journal.pone.0242405

Ejemplares similares